113 related articles for article (PubMed ID: 20530585)
1. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.
Hirano G; Izumi H; Kidani A; Yasuniwa Y; Han B; Kusaba H; Akashi K; Kuwano M; Kohno K
Mol Cancer Res; 2010 Jun; 8(6):864-72. PubMed ID: 20530585
[TBL] [Abstract][Full Text] [Related]
2. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.
Igarashi T; Izumi H; Uchiumi T; Nishio K; Arao T; Tanabe M; Uramoto H; Sugio K; Yasumoto K; Sasaguri Y; Wang KY; Otsuji Y; Kohno K
Oncogene; 2007 Jul; 26(33):4749-60. PubMed ID: 17297441
[TBL] [Abstract][Full Text] [Related]
3. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
Li H; Niederkorn JY; Neelam S; Alizadeh H
Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
El-Khoury V; Breuzard G; Fourré N; Dufer J
Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
[TBL] [Abstract][Full Text] [Related]
7. Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line.
Asechi H; Hatano E; Nitta T; Tada M; Iwaisako K; Tamaki N; Nagata H; Narita M; Yanagida A; Ikai I; Uemoto S
Int J Oncol; 2010 Jul; 37(1):89-96. PubMed ID: 20514400
[TBL] [Abstract][Full Text] [Related]
8. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines.
Tanabe M; Izumi H; Ise T; Higuchi S; Yamori T; Yasumoto K; Kohno K
Cancer Res; 2003 Dec; 63(24):8592-5. PubMed ID: 14695168
[TBL] [Abstract][Full Text] [Related]
9. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
10. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
Yang BF; Xiao C; Li H; Yang SJ
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
12. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
Tsunoda T; Koga H; Yokomizo A; Tatsugami K; Eto M; Inokuchi J; Hirata A; Masuda K; Okumura K; Naito S
Oncogene; 2005 Feb; 24(8):1396-402. PubMed ID: 15608674
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
Nagatani G; Nomoto M; Takano H; Ise T; Kato K; Imamura T; Izumi H; Makishima K; Kohno K
Cancer Res; 2001 Feb; 61(4):1592-7. PubMed ID: 11245470
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of p27 is associated with the cisplatin resistance in gastric cancer cell line YCC-3.
Le TV; Seo Y; Ryu CJ; Lee HR; Park HJ
Arch Pharm Res; 2010 Jul; 33(7):1127-32. PubMed ID: 20661724
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
Liu T; Liu PY; Tee AE; Haber M; Norris MD; Gleave ME; Marshall GM
Eur J Cancer; 2009 Jul; 45(10):1846-54. PubMed ID: 19342222
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma.
Ota T; Jono H; Ota K; Shinriki S; Ueda M; Sueyoshi T; Nakatani K; Hiraishi Y; Wada T; Fujita S; Obayashi K; Shinohara M; Ando Y
Oncol Rep; 2012 May; 27(5):1674-80. PubMed ID: 22344722
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.
Wu ZZ; Lu HP; Chao CC
Biochem Pharmacol; 2010 Jul; 80(2):262-76. PubMed ID: 20361941
[TBL] [Abstract][Full Text] [Related]
19. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
